Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Fluzone Influenza Virus Vaccine (2006-2007 Formulation).
Phase of Trial: Phase IV
Latest Information Update: 10 Apr 2014
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Sanofi; sanofi pasteur
- 11 May 2010 Official Title amended as reported by ClinicalTrials.gov.
- 24 Sep 2008 Actual patient numbers (31) added as reported by ClinicalTrials.gov
- 24 Sep 2008 Official Title and primary outcome amended as reported by ClinicalTrials.gov